Rituximab may be superior to natalizumab for relapse-remitting multiple sclerosis Physician's Weekly, 04 Jun 2023 Bookmark 1. For patients with relapsing-remitting multiple sclerosis (RRMS), rituximab demonstrated greater effectiveness at…